4.5 Article

SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 25, Issue 5, Pages 1749-1763

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.25.5.1749-1763.2005

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA091792, CA91792-01, R01 CA072150, R29 CA072150, CA72150-07] Funding Source: Medline
  2. NIDCR NIH HHS [DE14136-01, R01 DE014136] Funding Source: Medline

Ask authors/readers for more resources

The stability of cell cycle checkpoint and regulatory proteins is controlled by the ubiquitin-proteasome degradation machinery. A critical regulator of cell cycle molecules is the E3 ubiquitin ligase SCFSkp2, known to facilitate the polyubiquitination and degradation of p27, E2F, and c-myc. SCFSkp2 is frequently deregulated in human cancers. In this study, we have revealed a novel link between the essential Epstein-Barr virus (EBV) nuclear antigen EBNA3C and the SCFSkp2 Complex, providing a mechanism for cell cycle regulation by EBV. EBNA3C associates with cyclin A/cdk2 complexes, disrupting the kinase inhibitor p27 and enhancing kinase activity. The recruitment of SCFSkP2 activity to cyclin A complexes by EBNA3C results in ubiquitination and SCFSkp2-dependent degradation of p27. This is the first report of a viral protein usurping the function of the SCFSkp2 cell cycle regulatory machinery to regulate p27 stability, establishing the foundation for a mechanism by which EBV regulates cyclin/cdk activity in human cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available